Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
8 Immune correlates associated with clinical outcomes in patients with advanced malignancies treated with avelumab and OX40 agonist
Compose a Response to This Article
Other responses
No responses have been published for this article.
